Remedy Entertainment is best known for single player titles like Control and Alan Wake. However, the studio is looking to explore other areas of the video game world with a new free-to-play PvPvE title, codenamed Vanguard.
Vanguard is a little longer in coming
The company has now announced that their new title will remain in pre-production a little longer than originally planned, which is why they are now lowering their 2022 revenue and operating profit outlook slightly. Keeping the game in the proof-of-concept phase longer helps the team better prepare and test their new game before a larger team is needed for the next phase of development, CEO Tero Virtala writes in a related statement.
“Remedy is currently working on five world-class game titles, and our ability to develop these games is stronger than ever. With our transition to a multi-project operating model, we’ve learned that it’s better to continue our game projects for a longer period of time to keep in the early stages of development than in the past.The benefit of this is that the size of the team and therefore the operational costs remain lower and the teams have the time they need to design, prepare, and create important elements of the game testing before the project moves into a larger development phase that requires a larger team, thereby supporting both high-quality and cost-effective game development.
We have decided to keep the game, codenamed Vanguard, longer in its current proof-of-concept phase and postpone the significant expansion of the development team until 2023. This will shift revenue from 2022 to 2023. We therefore assume that our expected sales for 2022 will remain at the previous year’s level and our operating result will decrease significantly compared to 2021.”
Gamers will have to wait a little longer for Remedy Entertainment’s new multiplayer title, but the studio is currently working on a few other projects. Next we can probably expect the release of Alan Wake 2 in 2023. A sequel to Control and remakes of Max Payne 1 and 2 are also in development.